Search Results - "LAU, Cecilia"

Refine Results
  1. 1

    Curcumin: An age-old anti-inflammatory and anti-neoplastic agent by Fadus, Matthew C., Lau, Cecilia, Bikhchandani, Jai, Lynch, Henry T.

    “…Curcumin is a natural anti-inflammatory agent that has been used for treating medical conditions for many years. Several experimental and pharmacologic trials…”
    Get full text
    Journal Article
  2. 2

    Preclinical evaluation of the mTOR–PI3K inhibitor BEZ235 in nasopharyngeal cancer models by Ma, Brigette B.Y, Lui, Vivian W.Y, Hui, Connie W.C, Lau, Cecilia P.Y, Wong, Chi H, Hui, Edwin P, Ng, Margaret H.L, Cheng, Suk H, Tsao, Sai W, Tsang, Chi-Man, Cheung, Crystal S.F, Ho, Kakiu, Chan, Anthony T.C

    Published in Cancer letters (01-02-2014)
    “…Abstract The dual PI3K–mTOR inhibitor BEZ235 was evaluated in preclinical models of nasopharyngeal carcinoma (NPC). The IC50 value of BEZ235 for growth was in…”
    Get full text
    Journal Article
  3. 3

    Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines by Ma, Brigette B. Y., Lui, Vivian W. Y., Hui, Connie W. C., Lau, Cecilia P. Y., Wong, Chi-Hang, Hui, Edwin P., Ng, Margaret H., Tsao, S. W., Li, Yan, Chan, Anthony T. C.

    Published in Investigational new drugs (01-06-2013)
    “…Summary Nasopharyngeal carcinoma (NPC) is endemic to Asia and over 40 % of NPC tissues harbor PIK3CA amplifications. This study characterized the preclinical…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma by Wong, Chi Hang, Loong, Herbert H., Hui, Connie W. C., Lau, Cecilia P. Y., Hui, Edwin P., Ma, Brigette B. Y., Chan, Anthony T. C.

    Published in Investigational new drugs (01-12-2013)
    “…Summary Nasopharyngeal carcinoma (NPC) is common in Southeast Asia and over 40 % of NPC tissues have PIK3CA amplification. This study characterized the…”
    Get full text
    Journal Article
  6. 6

    Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19: A protocol for a pragmatic clinical trial by Chen, Justin Z, Hoang, Holly L, Yaskina, Maryna, Kabbani, Dima, Doucette, Karen E, Smith, Stephanie W, Lau, Cecilia, Stewart, Jackson, Zurek, Karen, Schultz, Morgan, Cervera, Carlos

    Published in PloS one (23-03-2022)
    “…The use of broad-spectrum antibiotics is widespread in patients with COVID-19 despite a low prevalence of bacterial co-infection, raising concerns for the…”
    Get full text
    Journal Article
  7. 7

    The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines by Ma, Brigette B. Y., Lui, Vivian W. Y., Hui, Edwin P., Lau, Cecilia P. Y., Ho, Kakiu, Ng, Margaret H. L., Cheng, S. H., Tsao, Sai-Wah, Chan, Anthony T. C.

    Published in Investigational new drugs (01-08-2010)
    “…Summary Phosphorylated (pi-) protein kinase B (AKT) is commonly expressed in nasopharyngeal carcinoma (NPC) cell lines and tissues, suggesting the involvement…”
    Get full text
    Journal Article
  8. 8

    Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma by Chan, Stephen L., Wong, Chi-Hang, Lau, Cecilia P. Y., Zhou, Qian, Hui, Connie W. C., Lui, Vivian W. Y., Ma, Brigette B. Y., Chan, Anthony T. C., Yeo, Winnie

    Published in Cancer chemotherapy and pharmacology (01-06-2013)
    “…Purpose RAD001 targets at the mammalian target of rapamycin (mTOR), while TKI-258 is a potent tyrosine kinase inhibitor targeting at fibroblast growth factor…”
    Get full text
    Journal Article
  9. 9

    Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma by Hui, Edwin Pun, Lui, Vivian W. Y., Wong, Cesar S. C., Ma, Brigette B. Y., Lau, Cecilia P. Y., Cheung, Crystal S. F., Ho, Kakiu, Cheng, Suk-hang, Ng, Margaret H. L., Chan, Anthony T. C.

    Published in Investigational new drugs (01-12-2011)
    “…Summary Purpose : Sunitinib is a multi-target receptor tyrosine kinase (RTK) inhibitor against vascular endothelial growth factor receptors, platelet-derived…”
    Get full text
    Journal Article
  10. 10

    High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies by Poon, Ronnie T P, Lau, Cecilia, Pang, Roberta, Ng, Kelvin K, Yuen, Jimmy, Fan, Sheung Tat

    Published in Annals of surgical oncology (01-06-2007)
    “…Radiofrequency ablation (RFA) is a recently developed treatment for hepatocellular carcinoma (HCC). Thus far, the prognostic impact of tumor biomarkers has not…”
    Get full text
    Journal Article
  11. 11

    Tissue Factor Expression Correlates with Tumor Angiogenesis and Invasiveness in Human Hepatocellular Carcinoma by POON, Ronnie Tung-Ping, LAU, Cecilia Pik-Yuk, HO, Joanna Wen-Ying, YU, Wan-Ching, FAN, Sheung-Tat, WONG, John

    Published in Clinical cancer research (01-11-2003)
    “…Purpose: Recent studies have shown that tissue factor (TF) may be involved in tumor angiogenesis and metastasis. The role of TF in hepatocellular carcinoma…”
    Get full text
    Journal Article
  12. 12

    Significance of circulating endothelial progenitor cells in hepatocellular carcinoma by Ho, Joanna W. Y., Pang, Roberta W. C., Lau, Cecilia, Sun, Chris K., Yu, Wan Ching, Fan, Sheung Tat, Poon, Ronnie T. P.

    Published in Hepatology (Baltimore, Md.) (01-10-2006)
    “…This study evaluated the significance of circulating bone marrow‐derived endothelial progenitor cells (EPCs) in patients with hepatocellular carcinoma (HCC), a…”
    Get full text
    Journal Article
  13. 13

    Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines by Ma, Brigette B. Y., Lui, Vivian W. Y., Cheung, Crystal S., Lau, Cecilia P. Y., Ho, Kakiu, Hui, Edwin P., Tsui, Stephen K. W., Ng, Margaret H., Cheng, S. H., Ng, Patrick K. S., Tsao, Sai Wai, Chan, Anthony T. C.

    Published in Investigational new drugs (01-02-2013)
    “…Summary This study evaluated the preclinical activity of selumetinib (AZD6244, ARRY-142866), an inhibitor of the mitogen-activated protein kinase kinase (MAPKK…”
    Get full text
    Journal Article
  14. 14

    Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma by POON, Ronnie Tung-Ping, LAU, Cecilia Pik-Yuk, CHEUNG, Siu-Tim, YU, Wun-Ching, FAN, Sheung-Tat

    Published in Cancer research (Chicago, Ill.) (15-06-2003)
    “…Recent studies have suggested that serum levels of vascular endothelial growth factor (VEGF) may provide useful prognostic information in patients with various…”
    Get full text
    Journal Article
  15. 15

    Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepatocellular Carcinoma: A Prospective Study by POON, Ronnie Tung-Ping, NG, Irene Oi-Lin, LAU, Cecilia, YU, Wun-Ching, YANG, Zhen-Fan, FAN, Sheung-Tat, WONG, John

    Published in Journal of clinical oncology (01-04-2002)
    “…This study prospectively evaluated the correlation of tumor microvessel density (MVD) with clinicopathologic features and postoperative recurrence in patients…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584 by Liu, Yuqing, Poon, Ronnie T, Li, Qinyu, Kok, Tsz Wai, Lau, Cecilia, Fan, Sheung Tat

    Published in Cancer research (Chicago, Ill.) (01-05-2005)
    “…Vascular endothelial growth factor (VEGF) plays an important role in tumor angiogenesis of hepatocellular carcinoma. Inhibition of VEGF receptors could…”
    Get full text
    Journal Article
  18. 18

    Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma by Tang, Terence-C, Poon, Ronnie-T, Lau, Cecilia-P, Xie, Dan, Fan, Sheung-Tat

    Published in World journal of gastroenterology : WJG (07-04-2005)
    “…AIM: Recent studies suggested that cyclooxygenase-2 (COX-2) enhances tumor angiogenesis via upregulation of vascular endothelial growth factor (VEGF). Although…”
    Get full text
    Journal Article
  19. 19

    Clinical Significance of Thrombospondin 1 Expression in Hepatocellular Carcinoma by Poon, Ronnie T, Chung, Ka Kit, Cheung, Siu Tim, Lau, Cecilia P, Tong, See Wai, Leung, Ka Ling, Yu, Wan Ching, Tuszynski, George P, Fan, Sheung Tat

    Published in Clinical cancer research (15-06-2004)
    “…Purpose: Thrombospondin 1 (THBS 1) is a matricellular protein capable of modulating angiogenesis. However, the actual role of THBS 1 in angiogenesis and tumor…”
    Get full text
    Journal Article
  20. 20